Cannabis News

Medical Marijuana, Inc. Subsidiary Kannaway Hires Jose Miguel Gutierrez Vazquez


SAN DIEGO, Calif., 06 Dec. 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chains, announced today today that its subsidiary Kannaway® hired Jose Miguel Gutierrez Vazquez as sales manager for its operations in Mexico.

“2021 has been an exciting year for us as we have added recognized leaders to our international team. I am confident that Miguel will be another great addition due to his extensive experience and well-established relationships in Mexico,” said Kannaway® CEO Blake Schroeder. “Our family of companies has been a pioneer in cannabidiol (CBD) sales in Mexico for many years, as we were the first to obtain legal import permits in Mexico in 2016. Latin America has always been an important area of ​​growth and revenue for us and we believe it will continue to be so under his leadership.

Vazquez has over 15 years of experience in marketing, advertising and sales and can boast a proven track record at one of the top nutrition companies. With an extensive background in nutrition and wellness, he has spent the past decade forming partnerships, launching new products, executing advertising campaigns, designing loyalty programs and doing market research in Mexico.

“Kannaway is leading the hemp revolution and I look forward to being part of their incredible journey to bring hemp into every home,” said Kannaway® Sales Manager, Mexico, Jose Miguel Gutierrez Vazquez. “The company’s high-quality cannabis products, coupled with their superior business model, are well positioned to contribute to positive global change. I am honored to be part of a world-class team and to support entrepreneurs across Mexico.

Mexico is on the verge of becoming the largest legal cannabis market in the world. According to Statistathe market value of CBD in Mexico was estimated to be around $9 million in 2020 and is expected to grow over 580%, to over $60 million, by 2024.

To learn more about Kannaway®, please visit https://kannaway.com/.

About Kannaway®

Kannaway® is a network sales and marketing company specializing in the sale and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, providing unique insight and opportunity for sales professionals who want to become successful leaders in the sale and marketing of botanicals. of hemp.

About Medical Marijuana, Inc.

We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct non-psychoactive cannabinoid business units: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in providing the highest quality non-psychoactive legal cannabis products derived from industrial hemp; and a clinical research and development sector for cannabinoid-based botanical drugs led by its pharmaceutical investment companies and partners, including AXIM® Biotechnologies, Inc.. and Neuropathix. Medical Marijuana, Inc. was named one of the top CBD producers by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina and Paraguay and is a leader in developing international markets. The company’s flagship product Genuine Scientific Hemp Oil has been used in several successful clinical studies in Mexico and Brazil to understand its safety and effectiveness.

Medical Marijuana, Inc. is headquartered in San Diego, CA and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To view the Medical Marijuana, Inc. corporate video, Click here.

PROSPECTIVE DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the safe harbor created by these articles. This document contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to differ materially from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

LEGAL DISCLOSURE

Medical Marijuana, Inc. does not sell or distribute products that violate the US Controlled Substances Act.

CONTACT:

Public relations contact:

Katherine Brown
PR account manager
CMW Media
858-264-6600
[email protected]
www.cmwmedia.com

Contact with Investor Relations:

T. (858) 283-4016
[email protected]



#Medical #Marijuana #Subsidiary #Kannaway #Hires #Jose #Miguel #Gutierrez #Vazquez

Related Posts

Leave a Reply